GVT Financial LP, the third-largest shareholder in obesity drugmaker Vivus Inc , intends to vote for the full slate of nine directors proposed by dissident investor First Manhattan Co, a source familiar with GVT's thinking said on Wednesday.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment